GlobeStar Therapeutics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
For the nine months, net loss was USD 1.18 million compared to USD 5.54 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0009 USD | -.--% | +20.00% | -.--% |
1st Jan change | Capi. | |
---|---|---|
+35.37% | 51.51B | |
-6.90% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+12.48% | 26.13B | |
-15.22% | 19.91B | |
+43.69% | 13.71B | |
+30.54% | 12.38B | |
-4.19% | 11.74B |